Angel Boardley is a dynamic business development professional with a strong foundation in biotechnology and biomedical sciences. With experience in venture capital, biorepository management, and client acquisition, she specializes in bridging the gap between scientific innovation and business strategy.

Angel has worked with leading institutions such as the National Cancer Institute, NIH, and Johns Hopkins, gaining expertise in research, data analysis, and biotech operations. She has played a key role in business growth initiatives, including securing funding, optimizing operational processes, and expanding client relationships in the life sciences sector.

Beyond her technical expertise, Angel is passionate about fostering diversity in STEM and entrepreneurship. She has spoken on numerous panels, sharing insights on navigating the biotech industry and advocating for underrepresented professionals. As an active member of organizations like Women in Bio and the Maryland Tech Council, she continues to drive innovation and collaboration within the industry.

With a unique blend of scientific knowledge and business acumen, Angel is committed to helping Azalea scale, innovate, and thrive.